Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Company Comment

    2 Big Problems For GlaxoSmithKline Plc

    | Leo Sun

    It's been a rough year for pharmaceutical giant GlaxoSmithKline plc (LON: GSK).

    Read more »

    Investing Articles

    4 Ways AstraZeneca plc Will Continue To Lead The Biotechnology Sector

    | Rupert Hargreaves

    How does AstraZeneca plc (LON: AZN) compare to its sector peers?

    Read more »

    Investing Articles

    Why I Hate AstraZeneca plc

    | Harvey Jones

    Aside from its 5.6% yield, Harvey Jones finds little to love about AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    4 Ways GlaxoSmithKline plc Will Continue To Lag The Biotechnology Sector

    | Rupert Hargreaves

    How does GlaxoSmithKline plc (LON: GSK) compare to its sector peers?

    Read more »

    Investing Articles

    21 Worrying Reasons Which Make AstraZeneca plc A Sell

    | Royston Wild

    Royston Wild reveals why shares in AstraZeneca plc (LON: AZN) are ready to shuttle lower.

    Read more »

    Investing Articles

    News Flow Makes Me Want To Buy AstraZeneca plc

    | Peter Stephens

    I’m thinking of buying AstraZeneca plc (LON: AZN) and here’s why…

    Read more »

    Investing Articles

    Neil Woodford: The Surprising Hero Of British Biotech

    | G A Chester

    Funding for British biotech has been drying up, but ace City investor Neil Woodford has ridden to the rescue.

    Read more »

    Investing Articles

    This Ratio Explains Why I’d Buy AstraZeneca plc Today

    | Roland Head

    AstraZeneca plc (LON:AZN) offers a 5.4% yield, but there's a more compelling reason to buy this firm's shares, as Roland…

    Read more »

    Investing Articles

    The Beginners’ Portfolio: What If We’d Bought AstraZenenca plc?

    | Alan Oscroft

    Did we do well to choose GlaxoSmithKline plc (LON: GSK) ahead of AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Google’s Healthcare Entrance Makes Me Bullish On AstraZeneca plc

    | Peter Stephens

    Google’s decision to launch a healthcare company makes me realise how great AstraZeneca plc (LON: AZN) really is.

    Read more »

    Investing Articles

    3 More FTSE 100 Shares To Avoid Market Madness: AstraZeneca plc, Severn Trent Plc and Smith & Nephew plc

    | David O'Hara

    Statistics show that shareholders in AstraZeneca plc (LON:AZN), Severn Trent Plc (LON:SVT) and Smith & Nephew plc (LON:SN) have avoided…

    Read more »

    Investing Articles

    The Surprising Sell Case For AstraZeneca plc

    | Royston Wild

    Royston Wild looks at a little-known share price catalyst for AstraZeneca plc (LON: AZN).

    Read more »